Glucose drives STAT3 activation in colorectal cancer cells, leading to tumor growth

Medical Xpress

March 4, 2026

Colorectal cancer is the third most common cancer in the United States. Although screening has led to a decrease in incidence over the past 20 years, early-onset colorectal cancer has been rising. Despite advances in surgery and therapies, patients with metastatic colorectal cancer continue to have poor outcomes, highlighting the need for novel treatments.